At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 180 enrolled
Drug / intervention
IDP-126 Gel +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris
In Brief
A Phase 3 clinical trial evaluating IDP-126 Gel and IDP-126 Vehicle Gel for Acne Vulgaris. Completed, enrolled 180 participants across 13 sites in 2 countries.
Detailed Summary
This is a multicenter, randomized, double-blind, vehicle-controlled, 12-week study designed to assess the safety, tolerability, and efficacy of IDP-126 Gel in comparison IDP-126 Vehicle Gel at Weeks 2, 4, 8, and 12.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesCanada, United States
Collaborators--
Timeline
Phase 3CompletedFinished
2020202120222023202420252026
First PostedJan 2020
Enrollment StartJan 2020
Primary CompletionMar 2021
TodayJul 2026
First PostedJan 2, 2020
Enrollment StartJan 27, 2020
Primary CompletionMar 18, 2021
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 6.5 years ago
Interventions
IDP-126 Geldrug
IDP-126 Gel applied topically to the face once daily for 12 weeks.
IDP-126 Vehicle Geldrug
IDP-126 Vehicle Gel applied topically to the face once daily for 12 weeks.